Babar Ghias

Babar Ghias has extensive work experience in the financial and biosciences industries. Babar currently holds the position of Chief Financial Officer at AvenCell since 2022. Prior to that, they served as the Chief Operating Officer at Castle Creek Biosciences, where they were responsible for developing personalized gene therapies for rare diseases. From 2017 to 2022, they worked as the Executive Vice President of Portfolio Management at Paragon Biosciences. Before that, they held various positions at Marathon Pharmaceuticals, LLC, including Chief Financial Officer and Head of Corporate Development and Strategy. Earlier in their career, they worked at Credit Suisse and UBS Securities (Pakistan) in roles related to mergers and acquisitions.

Babar Ghias completed their BSc (Hons.) in Economics / Mathematics from Lahore University of Management Sciences, which they attended from 1996 to 1999. Later, they pursued an MBA in Accounting and Finance from Washington University in St. Louis, attending from 2002 to 2004.